Cancer incidence and mortality in 23 000 patients with type 1 diabetes in the UK: Long‐term follow‐up
Anthony J. Swerdlow(Institute of Cancer Research), Minouk J. Schoemaker(Institute of Cancer Research), Michael E. Jones(Institute of Cancer Research), W. Gatling(Poole Hospital), Norman Waugh(University of Warwick), Kathleen M. Gillespie(Institute of Infection and Immunity), Andrew D. Morris(Health Data Research UK), Christopher Patterson(University of Wollongong), Johannes L. Botha(Leeds College of Building), S. D. Slater(The White House), A C Burden(Honiton Hospital)
Cited by 15
Related Papers
(untitled)
|Edinburgh Research Explorer (University of Edinburgh)|0|2.3k
SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout
|Nature Genetics|2008|806
Genome-wide association study identifies five susceptibility loci for glioma
|Nature Genetics|2009|797
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes
|Nature Genetics|2007|725
Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants
|JNCI Journal of the National Cancer Institute|2015|570